Extremity sarcomas: an analysis of prognostic factors from the Intergroup Rhabdomyosarcoma Study III

Area of Science:

• Pediatric Oncology
• Surgical Oncology
• Medical Statistics

Background:

• Extremity sarcomas in children pose significant treatment challenges.
• Previous studies analyzed Intergroup Rhabdomyosarcomas Studies (IRS) I and II for prognostic factors.
• This study focuses on the IRS III data to refine understanding of prognostic indicators.

Purpose of the Study:

• To review the experience of the Intergroup Rhabdomyosarcomas Studies (IRS) III regarding extremity sarcomas.
• To evaluate pretreatment factors for a new staging system in IRS IV.
• To report treatment outcomes for extremity sarcomas within the IRS III cohort.

Main Methods:

• Retrospective review of patient charts from IRS III with extremity-site tumors.
• Survival rates estimated using Kaplan-Meier method and compared with log-rank test.
• Multivariate analysis performed on significant univariate prognostic factors.

Main Results:

• Age at diagnosis, nodal metastases, and distant metastases were significant predictors of survival by multivariate analysis.
• Tumor size approached statistical significance as a prognostic factor.
• Both clinical grouping and pretreatment staging systems predicted survival differences; complete excision is preferred.

Conclusions:

• Clinical grouping and the IRS IV pretreatment staging system effectively predict survival in pediatric extremity sarcomas.
• Nodal metastases, distant metastases, tumor size, and age are significant prognostic factors.
• Complete surgical excision with clear margins is essential for treating extremity rhabdomyosarcomas.